Fast-growing Colorado Medicinal Cannabis Company Turns to Proven LED Grow Light Technology for Consistent Yields and Product Profiles
Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent LED lighting technology for greenhouse and controlled plant growth environments, announces an order from Revered of Aurora, Colorado. A respected leader in Colorado’s medicinal and adult use cannabis market since 2014, Revered will install Heliospectra LX60 intelligent LED grow lights as the company continues to expand its cultivation, operations and branded product portfolio. The order is valued at 741,740 SEK ($88,130 USD).
Revered is focused on premium cannabis flower cultivation and concentrate extraction processes with a portfolio of live resins, distillates and tinctures that includes the Quest Concentrates and Quest AeroInhaler brands. Revered selected the Heliospectra solution following a technical and financial review of a range of horticultural lighting products, including conventional HPS and metal halide fixtures.
“The Heliospectra adjustable spectrum LX60 lights offer Revered a proven solution to control yields and most importantly deliver consistent, highest-quality products to our customers with each harvest cycle,” said Christopher Hardiman, General Manager and co-founder of Revered. “Our innovative extraction processes create potent, pharmaceutical-grade products with predictable, measured and metered doses. The ability to control the LED light and spectra in real-time and at each point of the plant growth cycle ensures that our products start with the healthiest plants and trichome-rich flowers possible.”
As cannabis industry investments scale in Colorado, Revered and other companies have adopted a vertically integrated business structure with in-house cultivation and processing to ensure standardized products and cannabinoid profiles. By deploying Heliospectra’s proven LED grow light technology and customizable lighting strategies, Revered will be able to more accurately forecast yields while controlling utility costs and production cycles.
“Heliospectra provides a flexible and easy-to-use, full-spectrum LED lamp with market-leading software control to optimize crop quality and increase business performance for growers,” said Ali Ahmadian, CEO, Heliospectra. “Christopher Hardiman and his team at Revered exemplify the forward-thinking thought leadership needed in the cannabis industry today.”
The order will be visible in the accounts for Q4.
Ali Ahmadian, CEO of Heliospectra | +46 (0)72 203 6344 | [email protected]
Redeye is Heliospectra Certified Advisor for Nasdaq First North - www.redeye.se
About Revered Aurora & Quest Aerosols
Quest Aerosols is a Quest Concentrates and Revered Company. The Quest AeroInhaler delivery system is a unique solution on the market today. Recently recognized as 2017's "Invention of the Year" at Colorado's annual Cannabis Business Awards, the product and was recognized as the industry's most innovative for successfully synergizing pharmaceutical technology with cannabis extracts. To learn more about Quest Aerosols and the Quest AeroInhaler, please visit http://questaerosols.com/.
Heliospectra AB (publ) (OTCQB: HLS, FIRST NORTH: HELIO) is the industry’s most proven intelligent lighting technology for greenhouse and controlled plant growth environments. With the vision to make commercial crop production more connected and resource-efficient, growers and commercial producers across six continents use Heliospectra holistic and flexible solutions to consistently increase yields while producing crops that achieve quality appearance, superior nutritional or medicinal value and longer shelf life, harvest after harvest. Founded in 2006 and winner of multiple international awards and recognitions, Heliospectra has raised more than $32 million in capital to date. As a publicly traded company, the majority ownership remains with some of Heliospectra earliest investors Weland Steel, Swedish Industrial Fund and Midroc New Technology. For more information, please visit https://www.heliospectra.com.
The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.
This information is information that Heliospectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14.00 CEST / 8 AM EDT on December 21, 2017.